Editorial Information

Trinseo Continues its Focus on Drug Delivery Devices with Rigid and Soft Plastics

Company will Showcase Resins at Medtec Europe in Stuttgart, April 17 - 19

BERWYN, Pa. - Tuesday, April 17, 2018

Last year, Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, began supporting the Drug Delivery Devices market with its specialty engineered resins. The company has highlighted its materials at trade shows worldwide including MD&M West in California, Pharmapack in Paris, and the International Component Manufacturing and Design Show in Shanghai.

Trinseo will be showcasing its plastic resins at Medtec Europe in Stuttgart from April 17 to 19, co-located with one of its European distributor partners VELOX in Hall 9, Booth 9E38. 

Typical drug delivery devices, also known as pre-filled or combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The company’s specialty compounded solutions are ideal for a wide range of applications – MAGNUM™ ABS, CALIBRE™ Polycarbonate, STYRON Polystyrene, and EMERGE™ Advanced Resins for rigid plastic applications, and RAPLAN™ and MEGOL™ Thermoplastic Elastomers for soft touch and over molding needs.

Trinseo is ISO 13485 certified and a trusted partner of global product designers, manufacturers and molders of medical devices. Large and global in its infrastructure yet agile in its service model, the company is known for its quality, technical knowledge, and regulatory support services, which enable customers to lower risk and take products to market sooner.  

As the healthcare industry continues to look for ways to enhance patient care, improve quality of life, and reduce costs, self-administered therapies are providing a viable solution. Health care providers need devices that are effective therapeutically and also are convenient, functional and aesthetically pleasing.  Plastic resin materials are a big part of the solution. Trinseo, with nearly three decades of experience with medical polymers, is supporting global customers with this challenge.

Contact Wassim Berrak to arrange a time to meet at the show or connect with Trinseo at www.trinseo.com.

About Trinseo

Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.

From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.

Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Editorial Information

Get Exclusive Trinseo Content

Be the first to hear about new product information, company news, and more Trinseo updates conveniently via email!